Evidence map›Paper›PMID 36013483›Full record

ArticleMedicina (Kaunas, Lithuania)2022

Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization.

Guobin Chen, Hong Chen, Xing Huang, Sisi Cheng, Susu Zheng, Yanfang Wu, Tanghui Zheng, Xiaochun Chen, Xinkun Guo, Zhenzhen Zhang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Guobin ChenDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.ORCID 0000-0002-3587-7094
Hong ChenDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Xing HuangDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Sisi ChengDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Susu ZhengDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Yanfang WuDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Tanghui ZhengDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Xiaochun ChenDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Xinkun GuoDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Zhenzhen ZhangDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Xiaoying XieDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.
Boheng ZhangDepartment of Hepatic Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen 361015, China.

Funding

Health Youth Scientific research project in Fujian 2019-2-64Key Program of Xiamen Medical and Health 3502Z20191105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, HepatocellularCatheter AblationChemoembolization, TherapeuticLiver NeoplasmsHumansMicrowavesRetrospective StudiesTreatment Outcomechemoembolizationhepatocellular carcinomamicrowave thermotherapyrecurrence

Identifiers

PMID36013483
PMCPMC9412845

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.